Mechanism of Baoyuan Decoction in the Treatment of Chronic Heart Failure Based on Network Pharmacology

被引:0
|
作者
Yuan, Xianying [1 ]
Lv, Lina [1 ]
Wang, R. [2 ]
机构
[1] Changchun Univ Chinese Med, Coll Tradit Chinese Med, Changchun 130117, Jilin, Peoples R China
[2] Changchun Univ Chinese Med, Sch Nursing, Dept Clin Nursing 1, Changchun 130117, Jilin, Peoples R China
基金
中国国家自然科学基金;
关键词
Baoyuan decoction; chronic heart failure; oxidative stress; inflammatory reaction; cancer pathway;
D O I
10.36468/pharmaceutical-sciences.spl.367
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This study aims to explore the material basis and mechanism of Baoyuan decoction in the treatment of chronic heart failure by network pharmacology and molecular docking technology. There are 144 effective active ingredients and 253 targets in Baoyuan decoction. The key ingredients mainly include flavonoids such as quercetin, naringenin and glazin. There are 240 intersecting targets between Baoyuantang and chronic heart failure, and its core targets include jun proto-oncogene, signal transducer and activator of transcription 3, tumor protein 53, transcription factor p65, mitogen-activated protein kinase 14, estrogen receptor 1, etc. The gene ontology and kyoto encyclopedia of genes and genomes enrichment analysis results show that it mainly involves 2475 biological processes, 104 cell components, 253 molecular functions and 174 related signals pathway. It mainly regulates the evolutionary processes including nutritional response, inflammatory response, oxidative stress response, apoptosis signal pathway etc., through the cell components such as cytoplasm, cell membrane and synapse, and exerts the molecular functions of DNA binding transcription factor, RNA polymerase II specific DNA binding transcription factor, serine/threonine kinase activity, ubiquitin-like protein ligase binding, through phosphatidylinositol 3 kinase-protein kinase B, Mitogen-activated protein kinase 14, Advanced glycation end products-receptor for AGE, Interleukin-17, apoptosis, cancer and other signaling pathways to play a role in the treatment of chronic heart failure effect.
引用
收藏
页码:19 / 28
页数:10
相关论文
共 50 条
  • [21] Mechanism of Simiao Decoction in the treatment of atherosclerosis based on network pharmacology prediction and molecular docking
    Li, Qian
    Chai, Yihui
    Li, Wen
    Guan, Liancheng
    Fan, Yizi
    Chen, Yunzhi
    MEDICINE, 2023, 102 (36) : E35109
  • [22] Mechanism of Tao Hong Decoction in the treatment of atherosclerosis based on network pharmacology and experimental validation
    Li, SiJin
    Liu, Ping
    Feng, Xiaoteng
    Du, Min
    Zhang, Yifan
    Wang, YiRu
    Wang, JiaRou
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2023, 10
  • [23] Mechanism of Wenshen Xuanbi Decoction in the treatment of osteoarthritis based on network pharmacology and experimental verification
    You, Hankun
    Ren, Tongsen
    Yin, Song Jiang
    Wu, Peng
    Mao, Jun
    KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY, 2024, 28 (01): : 59 - 72
  • [24] Exploring the mechanism of Suanzaoren decoction in treatment of insomnia based on network pharmacology and molecular docking
    Wang, Shuxiao
    Zhao, Yan
    Hu, Xingang
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [25] Exploring the mechanism of Erchen decoction in the treatment of atherosclerosis based on network pharmacology and molecular docking
    Li, Wenwen
    Zhang, Guowei
    Zhao, Zhenfeng
    Zuo, Yaoyao
    Sun, Zhenhai
    Chen, Shouqiang
    MEDICINE, 2023, 102 (46) : E35248
  • [26] The mechanism of Sanzi Yangqin decoction for asthma treatment based on network pharmacology and experimental verification
    Wu, Yue
    Ni, Zhenhua
    Wang, Shiqiang
    Sun, Yipeng
    Luo, Xuming
    Wang, Xiongbiao
    Liu, Jinjin
    BMC COMPLEMENTARY MEDICINE AND THERAPIES, 2023, 23 (01)
  • [27] The mechanism of Sanzi Yangqin decoction for asthma treatment based on network pharmacology and experimental verification
    Yue Wu
    Zhenhua Ni
    Shiqiang Wang
    Yipeng Sun
    Xuming Luo
    Xiongbiao Wang
    Jinjin Liu
    BMC Complementary Medicine and Therapies, 23
  • [28] Molecular mechanism of Shengyang Yiwei Decoction in treating chronic kidney disease based on network pharmacology
    Lan, Xinpeng
    Ao, Wu Liji
    Li, Ji
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2023, 15 (12): : 6878 - 6887
  • [29] Network pharmacology and transcriptomics to determine Danggui Yifei Decoction mechanism of action for the treatment of chronic lung injury
    Guo, Jianning
    Liang, Junming
    Guo, Ziyi
    Bai, Xue
    Zhang, Hongxian
    Zhang, Ning
    Wang, Handong
    Chen, Qian
    Li, Wei
    Dong, Ruijuan
    Ge, Dongyu
    Yu, Xue
    Cui, Xia
    JOURNAL OF ETHNOPHARMACOLOGY, 2024, 318
  • [30] Mechanism of Astragalus membranaceus (Huangqi, HQ) for treatment of heart failure based on network pharmacology and molecular docking
    Chen, Qiuxiang
    Wang, Juan
    Sun, Lihua
    Ba, Bayinsilema
    Shen, Difei
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2024, 28 (10)